Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study
Alexis Ogdie, Sungat K. Grewal, Megan H. Noe, et al.
Journal of Investigative Dermatology (2017) Vol. 138, Iss. 4, pp. 760-767
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, et al.
Journal of the American Academy of Dermatology (2019) Vol. 80, Iss. 4, pp. 1073-1113
Closed Access | Times Cited: 379
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
Alan Menter, Joel M. Gelfand, Cody Connor, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 6, pp. 1445-1486
Open Access | Times Cited: 258
Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review
Jin Bu, Rui‐Lian Ding, Liang-Jia Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 145
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults
Zhijie Ruan, Tao Lu, Yanxia Chen, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 7, pp. 745-745
Open Access | Times Cited: 142
Current Concepts of Psoriasis Immunopathogenesis
Marijana Vičić, Marija Kaštelan, Ines Brajac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11574-11574
Open Access | Times Cited: 106
Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions
Lyn D Ferguson, Stefan Siebert, Iain B. McInnes, et al.
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 8, pp. 461-474
Open Access | Times Cited: 126
Comorbidities associated with psoriatic arthritis: Review and update
Lourdes M. Pérez-Chada, Joseph F. Merola
Clinical Immunology (2020) Vol. 214, pp. 108397-108397
Closed Access | Times Cited: 108
Systemic effects of IL-17 in inflammatory arthritis
Audrey Beringer, Pierre Miossec
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 8, pp. 491-501
Closed Access | Times Cited: 104
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies
Francesco Bellinato, Paolo Gisondi, Alessandro Mantovani, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 7, pp. 1277-1288
Open Access | Times Cited: 41
Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study
Joel M. Gelfand, Joy Wan, He Zhang, et al.
Journal of the American Academy of Dermatology (2021) Vol. 84, Iss. 6, pp. 1636-1643
Closed Access | Times Cited: 45
Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment
Shunsuke Mori, Nobuyuki Arima, Masahiro Ito, et al.
PLoS ONE (2018) Vol. 13, Iss. 8, pp. e0203084-e0203084
Open Access | Times Cited: 52
Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment
Junko Takeshita, Whitney Eriksen, Valerie T. Raziano, et al.
Journal of Investigative Dermatology (2019) Vol. 139, Iss. 8, pp. 1672-1679.e1
Open Access | Times Cited: 52
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients
Augusta Ortolan, Mariagrazia Lorenzin, Giulia Tadiotto, et al.
Clinical Rheumatology (2019) Vol. 38, Iss. 10, pp. 2843-2850
Closed Access | Times Cited: 47
Beyond skin deep: addressing comorbidities in psoriasis
Tom Kovitwanichkanont, Alvin H Chong, Peter Foley
The Medical Journal of Australia (2020) Vol. 212, Iss. 11, pp. 528-534
Open Access | Times Cited: 42
Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?
Johanna Heitmann, Verena Frings, Andreas Geier, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 4, pp. 517-528
Open Access | Times Cited: 35
Bidirectional Association Between Psoriasis and Nonalcoholic Fatty Liver Disease: Real-World Evidence From Two Longitudinal Cohort Studies
Shuo‐Yan Gau, Kuang‐Hua Huang, Chiu‐Hsiang Lee, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases
Jérôme Avouac, O. Fogel, Sophie Hecquet, et al.
Joint Bone Spine (2023) Vol. 90, Iss. 5, pp. 105592-105592
Open Access | Times Cited: 16
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
Deepak Balak, Stefano Piaserico, Ismail Kasujee
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 151-168
Open Access | Times Cited: 30
Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer
Qiushi Yin, Qiuxi Yang, Wenjie Shi, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2930-2930
Open Access | Times Cited: 12
Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study
Kevin Sheng‐Kai, Chee-Ming Lee, Po‐Hung Chen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Cristiano Campanholo, Ajesh B. Maharaj, Nadia Corp, et al.
The Journal of Rheumatology (2022), pp. jrheum.220310-jrheum.220310
Open Access | Times Cited: 18
Artritis psoriásica
A. López‐Ferrer, A. Laíz, L. Puig
Medicina Clínica (2022) Vol. 159, Iss. 1, pp. 40-46
Closed Access | Times Cited: 17
Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
Nuria Barbarroja, M. Ruiz-Ponce, L. Cuesta-López, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Predictive Performances of Blood-Count-Derived Inflammatory Markers for Liver Fibrosis Severity in Psoriasis Vulgaris
Oana Mirela Tiucă, Silviu Horia Morariu, Claudia Raluca Mariean, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16898-16898
Open Access | Times Cited: 10
The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
Suvijak Untaaveesup, Piyawat Kantagowit, Patompong Ungprasert, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1374-1374
Open Access
Page 1 - Next Page

Scroll to top